XNAS
HUMA
Market cap124mUSD
Oct 08, Last price
0.45USD
1D
-5.34%
1Q
-35.55%
IPO
-95.38%
Name
Humacyte Inc
Chart & performance
P/E
—
P/S
60.94
EPS
—
Div yield, %
—
Shrs. gr., 5y
66.26%
Rev. gr., 5y
6.45%
Revenues
2m
Net income
-41m
L-72.54%
CFO
-105m
L+7.05%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2020, Alpha Healthcare Acquisition Corp. operates as a special purpose acquisition company (SPAC), headquartered in New York, New York.
Key people
Laura Niklason
President, Chief Executive Officer, Director · since 2021
Dale Sander
Chief Financial Officer, Chief Corporate Development Officer, Treasurer · since 2021
Heather Prichard
Chief Operating Officer
Yang Cao
Chief Regulatory Officer · since 2022
Shamik Parikh
Chief Medical Officer · since 2022
William Scheessele
Chief Commercial Officer · since 2021
Director · since 2021
John Bamforth
Independent Director · since 2024
Emery Brown
Independent Director · since 2021
Michael Constantino
Independent Director · since 2021
C. Bruce Green
Independent Director · since 2022
Keith Jones
Independent Director · since 2024
Todd Pope
Independent Director · since 2021
Independent Chairman of the Board · since 2021
Diane Seimetz
Independent Director · since 2022
Max Wallace
Independent Director · since 2021
Susan Windham-Bannister
Independent Director · since 2021
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||